Brami nei internal and kollupodi themirthal extrernal for sirasthamba vatham (cerebral palsy) in children

Clinical evaluation of a Siddha drug Brahmi nei (Internal) and Kollu podi thimirthal (External) in the treatment of Sirasthambavatham (Cerebral palsy)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013283

Enrollment

Registered

2018-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- sirasthamba vatham cerebral palsy

Interventions

Intervention1: sirasthamba vatham cerebrl palsy: brami nei 2 to 5ml internal and kollu podi themirthal external for 21 days Control Intervention1: clinical evaluvation of sirasthamba vaatham cerebral

Eligibility

Inclusion criteria

Inclusion criteria: Monoplegia or diplegia or triplegia or Quadri plegia Hypertonia of upper or lower limb muscles Difficulty in use against gravity of both upper and lower limb

Exclusion criteria

Exclusion criteria: Epilepsy Severe aggressive with ADHD Congenital heart disease Any other serious illness Autism

Design outcomes

Primary

Measure	Time frame
Asworth scaleTimepoint: to reduce the muscle spasticity	—

Secondary

Measure	Time frame
Asworth scaleTimepoint: increase the nerve strength and muscle stregnth	—

Countries

India

Contacts

Public ContactG Ridhambara devi

National institute of siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026